Template:Bone and cartilage mass differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
(8 intermediate revisions by 2 users not shown) | |||
Line 9: | Line 9: | ||
!Genetic Studies | !Genetic Studies | ||
|- | |- | ||
| '''Adamantinoma''' | | '''[[Adamantinoma]]''' | ||
| | | | ||
* 20-30 yo males | * 20-30 yo males | ||
Line 32: | Line 32: | ||
* CK19 +ve | * CK19 +ve | ||
|- | |- | ||
| '''Ameloblastoma''' | | '''[[Ameloblastoma]]''' | ||
| | | | ||
* 30-50 yo patients | * 30-50 yo patients | ||
Line 56: | Line 56: | ||
* V600E | * V600E | ||
|- | |- | ||
|'''Aneurysmal bone cyst''' | |'''[[Aneurysmal bone cyst]]''' | ||
| | | | ||
* 10-20 yo patients | * 10-20 yo patients | ||
Line 79: | Line 79: | ||
* Translocation t(16;17)(q22;p13) | * Translocation t(16;17)(q22;p13) | ||
|- | |- | ||
| '''Unicameral bone cyst''' | | '''[[Unicameral bone cyst]]''' | ||
| | | | ||
* 10-20 yo patients | * 10-20 yo patients | ||
Line 93: | Line 93: | ||
* No periosteal reaction | * No periosteal reaction | ||
* Thinning of the endosteum and pseudotrabeculation | * Thinning of the endosteum and pseudotrabeculation | ||
| * Cysts contain clear serosanguineous fluid | | | ||
* Cysts contain clear serosanguineous fluid | |||
* Fibrous membranous lining | * Fibrous membranous lining | ||
| * TP53 mutations | | | ||
* TP53 mutations | |||
|- | |- | ||
|''' Brown tumor''' | |''' [[Brown tumor]]''' | ||
| | | | ||
* 40-50 yo females | * 40-50 yo females | ||
Line 113: | Line 115: | ||
* Giant cells with round to oval nuclei and nucleoli | * Giant cells with round to oval nuclei and nucleoli | ||
* Elevated number of osteoblast and osteoclast | * Elevated number of osteoblast and osteoclast | ||
| * MEN1 gene | | | ||
* MEN1 gene | |||
* RET oncogene | * RET oncogene | ||
|- | |- | ||
| '''Chondroblastoma''' | | '''[[Chondroblastoma]]''' | ||
| | | | ||
* <20 yo males | * <20 yo males | ||
Line 138: | Line 141: | ||
* Vimentin +ve | * Vimentin +ve | ||
|- | |- | ||
| '''Chondromyxoid fibroma''' | | '''[[Chondromyxoid fibroma]]''' | ||
| | | | ||
* Progressive bone pain | * Progressive bone pain | ||
Line 161: | Line 164: | ||
* SOX9 +ve | * SOX9 +ve | ||
|- | |- | ||
| '''Chondrosarcoma''' | | '''[[Chondrosarcoma]]''' | ||
| | | | ||
* 50-70 yo males | * 50-70 yo males | ||
Line 186: | Line 189: | ||
* Collagen II +ve | * Collagen II +ve | ||
|- | |- | ||
| '''Desmoplastic fibroma''' | | '''[[Desmoplastic fibroma]]''' | ||
| | | | ||
* 20 yo patients | * 20 yo patients | ||
Line 200: | Line 203: | ||
* Non-sclerotic margins | * Non-sclerotic margins | ||
* Internal pseudotrabeculation | * Internal pseudotrabeculation | ||
| * Mature, bland fibroblasts | | | ||
* Mature, bland fibroblasts | |||
* Little cellularity, no pleomorphism | * Little cellularity, no pleomorphism | ||
* Abundant collagenous stroma | * Abundant collagenous stroma | ||
Line 208: | Line 212: | ||
*Beta-catenin | *Beta-catenin | ||
|- | |- | ||
| '''Enchondroma''' | | '''[[Enchondroma]]''' | ||
| | | | ||
* 10-30 yo patients | * 10-30 yo patients | ||
Line 215: | Line 219: | ||
* Maffuci syndrome and Ollier disease | * Maffuci syndrome and Ollier disease | ||
| | | | ||
* Widening of the bone | *Widening of the bone | ||
*Limb-length discrepancy | *Limb-length discrepancy | ||
* Angular deformity | * Angular deformity | ||
Line 233: | Line 237: | ||
* Ki-MCM6 | * Ki-MCM6 | ||
|- | |- | ||
| '''Ewing sarcoma''' | | '''[[Ewing sarcoma]]''' | ||
| | | | ||
* 10-20 yo males | * 10-20 yo males | ||
Line 259: | Line 263: | ||
* FLI-1 +ve | * FLI-1 +ve | ||
|- | |- | ||
| '''Fibrosarcoma''' | | '''[[Fibrosarcoma]]''' | ||
| | | | ||
* 30-60 yo males | * 30-60 yo males | ||
Line 275: | Line 279: | ||
* Periosteal reaction is uncommon | * Periosteal reaction is uncommon | ||
| | | | ||
* Elevated mitotic activity* Highly cellular fibroblastic proliferation | * Elevated mitotic activity | ||
* Highly cellular fibroblastic proliferation | |||
* Herring bone pattern and spindle cell lesions | * Herring bone pattern and spindle cell lesions | ||
* Long dark nuclei with increased granular chromatin | * Long dark nuclei with increased granular chromatin | ||
Line 282: | Line 287: | ||
* Vimentin +ve | * Vimentin +ve | ||
|- | |- | ||
| '''Fibrous dysplasia''' | | '''[[Fibrous dysplasia]]''' | ||
| | | | ||
*10-20 yo patients | *10-20 yo patients | ||
Line 305: | Line 310: | ||
* GNAS1 gene | * GNAS1 gene | ||
|- | |- | ||
| '''Giant cell tumor''' | | '''[[Giant cell tumor]]''' | ||
| | | | ||
* 20-30 yo female | * 20-30 yo female | ||
Line 320: | Line 325: | ||
* Intratumoral hemorrhage present | * Intratumoral hemorrhage present | ||
* Tumor extends into the subchondral plate | * Tumor extends into the subchondral plate | ||
| * Uniform and regular distribution of multinucleated giant cells and mononuclear stromal cells | | | ||
* Uniform and regular distribution of multinucleated giant cells and mononuclear stromal cells | |||
* Hemorrhage, necrosis, and hemosiderin deposition | * Hemorrhage, necrosis, and hemosiderin deposition | ||
* Elevated mitotic figures | * Elevated mitotic figures | ||
Line 329: | Line 335: | ||
* Ki-67 +ve | * Ki-67 +ve | ||
|- | |- | ||
| '''Ossifying fibroma''' | | '''[[Ossifying fibroma]]''' | ||
| | | | ||
* 1-5 yo children | * 1-5 yo children | ||
Line 341: | Line 347: | ||
| | | | ||
* Well-circumscribed lesion | * Well-circumscribed lesion | ||
* Intracortical osteolysis* Sclerotic band (osteoblastic rimming) | * Intracortical osteolysis | ||
* Sclerotic band (osteoblastic rimming) | |||
* Cortical expansion | * Cortical expansion | ||
* Homogeneous lesion matrix | * Homogeneous lesion matrix | ||
Line 351: | Line 358: | ||
* Over expression of Runx2 | * Over expression of Runx2 | ||
|- | |- | ||
| '''Osteoblastoma''' | | '''[[Osteoblastoma]]''' | ||
| | | | ||
* 20-30 yo males | * 20-30 yo males | ||
Line 375: | Line 382: | ||
* p53 protein expression and high PCNA index. | * p53 protein expression and high PCNA index. | ||
|- | |- | ||
| '''Osteochondroma''' | | '''[[Osteochondroma]]''' | ||
| | | | ||
* < 20 yo males | * < 20 yo males | ||
Line 391: | Line 398: | ||
* Irregular subchondral bone | * Irregular subchondral bone | ||
* Projecting away from the epiphysis | * Projecting away from the epiphysis | ||
| * Composed of bone, cartilage, and perichondrium | | | ||
* Composed of bone, cartilage, and perichondrium | |||
* Pink fibrous capsule | * Pink fibrous capsule | ||
* Normal bony trabeculae | * Normal bony trabeculae | ||
Line 399: | Line 407: | ||
* 11p11-12 | * 11p11-12 | ||
|- | |- | ||
| '''Osteoid osteoma''' | | '''[[Osteoid osteoma]]''' | ||
| | | | ||
* 10-35 yo males | * 10-35 yo males | ||
Line 422: | Line 430: | ||
* PTEN mutation | * PTEN mutation | ||
|- | |- | ||
| '''Osteosarcoma''' | | '''[[Osteosarcoma]]''' | ||
| | | | ||
* 10-20 yo males* Bone pain and swelling | * 10-20 yo males | ||
* Bone pain and swelling | |||
* Pathologic fracture | * Pathologic fracture | ||
* History of Paget disease of bone or irradiation | * History of Paget disease of bone or irradiation | ||
Line 446: | Line 455: | ||
* RB1 tumor suppressor gene | * RB1 tumor suppressor gene | ||
|- | |- | ||
| '''Plasmacytoma''' | | '''[[Plasmacytoma]]''' | ||
| * 55-60 yo males* Back pain* Pathological fracture* Palpable vertebral mass | | | ||
| * Palpable bony lump | * 55-60 yo males | ||
| * Elevated monoclonal antibodies | * Back pain | ||
| * Well-defined, “punched-out” lytic lesions | * Pathological fracture | ||
* Palpable vertebral mass | |||
| | |||
* Palpable bony lump | |||
| | |||
* Elevated monoclonal antibodies | |||
| | |||
* Well-defined, “punched-out” lytic lesions | |||
* Marked erosion, expansion, and destruction of bone cortex | * Marked erosion, expansion, and destruction of bone cortex | ||
* Thick ridging around the periphery | * Thick ridging around the periphery | ||
Line 459: | Line 475: | ||
* Unregulated expression of cMYC with KRAS12V in T2 B cells | * Unregulated expression of cMYC with KRAS12V in T2 B cells | ||
|- | |- | ||
| '''Eosinophilic Granuloma''' | | '''[[Eosinophilic Granuloma]]''' | ||
| | | | ||
* 5-10 yo males* Local bone pain | * 5-10 yo males | ||
* Local bone pain | |||
* Failure to thrive | * Failure to thrive | ||
* Spontenously resolve | * Spontenously resolve | ||
Line 478: | Line 495: | ||
* Elevated expression of p53, c-myc, and H-ras | * Elevated expression of p53, c-myc, and H-ras | ||
|- | |- | ||
| '''Brodie abscess''' | | '''[[Brodie abscess]]''' | ||
| | | | ||
* 5-15 yo males* Nocturnal pain | * 5-15 yo males | ||
* Nocturnal pain | |||
* Rapid response to analgesics | * Rapid response to analgesics | ||
* Mimics | * Mimics osteoid osteoma | ||
| | | | ||
* Tender, localized and painful mass | * Tender, localized and painful mass | ||
Line 491: | Line 509: | ||
| | | | ||
*Lytic lesion often in an oval configuration | *Lytic lesion often in an oval configuration | ||
* Surrounded by thick dense rim of reactive sclerosis | *Surrounded by thick dense rim of reactive sclerosis | ||
*Lucent tortuous channel extending toward growth plate prior to physeal closure (pathognomonic) | *Lucent tortuous channel extending toward growth plate prior to physeal closure (pathognomonic) | ||
*Common location is the epiphysis long axis of long bones | *Common location is the epiphysis long axis of long bones | ||
Line 499: | Line 517: | ||
* There are no genetic studies associated | * There are no genetic studies associated | ||
|- | |- | ||
| '''Osteoma''' | | '''[[Osteoma]]''' | ||
| | | | ||
* 20-35 yo females | * 20-35 yo females | ||
Line 517: | Line 535: | ||
* APC gene mutation, present in multiple forms | * APC gene mutation, present in multiple forms | ||
|- | |- | ||
| '''Intraosseous lipoma''' | | '''[[Intraosseous lipoma]]''' | ||
| | | | ||
* 5-85yo, males | * 5-85yo, males | ||
Line 534: | Line 552: | ||
* Translocation t(3;12)(q28;q14) | * Translocation t(3;12)(q28;q14) | ||
|- | |- | ||
| '''Enostosis''' | | '''[[Enostosis]]''' | ||
| | | | ||
* No age or gender predilection | * No age or gender predilection | ||
Line 551: | Line 569: | ||
* Associated mutation is LEMD3 gene | * Associated mutation is LEMD3 gene | ||
|- | |- | ||
| '''Chordoma''' | | '''[[Chordoma]]''' | ||
| * 30-70 yo, no gender predilection | | | ||
* 30-70 yo, no gender predilection | |||
* Slow growing tumor, commonly found in caucasians | * Slow growing tumor, commonly found in caucasians | ||
* Originate from embryonic remnants of the primitive notochord | * Originate from embryonic remnants of the primitive notochord | ||
Line 561: | Line 580: | ||
| | | | ||
* Well-circumcised, lytic lesion with marginal sclerosis. | * Well-circumcised, lytic lesion with marginal sclerosis. | ||
*Intratumoral calfications *Distrubtion is along the axial skeleton | *Intratumoral calfications | ||
*Distrubtion is along the axial skeleton | |||
*Common locations, include: sacrococcygeal, spheno-occipital: 30-35% vertebral bodies | *Common locations, include: sacrococcygeal, spheno-occipital: 30-35% vertebral bodies | ||
| | | | ||
Line 568: | Line 588: | ||
* Associated with the duplication of T gene | * Associated with the duplication of T gene | ||
|- | |- | ||
| '''Bone metastasis''' | | '''[[Bone metastasis]]''' | ||
| | | | ||
* No age or gender predilection | * No age or gender predilection | ||
Line 579: | Line 599: | ||
*Increase in hydroxyproline excretion may also be present | *Increase in hydroxyproline excretion may also be present | ||
| | | | ||
*Three- | *Three-patterns may be observed: lytic, sclerotic, and mixed | ||
*Morphological characteristics may vary: expansile, focal or diffuse | *Morphological characteristics may vary: expansile, focal or diffuse | ||
*Common locations, include: axial skeleton, and long bones | *Common locations, include: axial skeleton, and long bones | ||
Line 587: | Line 607: | ||
* Associated mutation will vary depending on primary tumor | * Associated mutation will vary depending on primary tumor | ||
|- | |- | ||
| '''Intraosseous ganglion''' | | '''[[Intraosseous ganglion]]''' | ||
| | | | ||
* 30-50, no gender predilection | * 30-50, no gender predilection |
Latest revision as of 17:03, 8 February 2016
Disease Name | History & Symptoms | Physical Exam | Lab Findings | Imaging Findings | Histologic Findings | Genetic Studies |
---|---|---|---|---|---|---|
Adamantinoma |
|
|
|
|
|
|
Ameloblastoma |
|
|
|
|
|
|
Aneurysmal bone cyst |
|
|
|
|
|
|
Unicameral bone cyst |
|
|
|
|
|
|
Brown tumor |
|
|
|
|
|
|
Chondroblastoma |
|
|
|
|
|
|
Chondromyxoid fibroma |
|
|
|
|
|
|
Chondrosarcoma |
|
|
|
|
|
|
Desmoplastic fibroma |
|
|
|
|
|
|
Enchondroma |
|
|
|
|
|
|
Ewing sarcoma |
|
|
|
|
|
|
Fibrosarcoma |
|
|
|
|
|
|
Fibrous dysplasia |
|
|
|
|
|
|
Giant cell tumor |
|
|
|
|
|
|
Ossifying fibroma |
|
|
|
|
|
|
Osteoblastoma |
|
|
|
|
|
|
Osteochondroma |
|
|
|
|
|
|
Osteoid osteoma |
|
|
|
|
|
|
Osteosarcoma |
|
|
|
|
|
|
Plasmacytoma |
|
|
|
|
|
|
Eosinophilic Granuloma |
|
|
|
|
|
|
Brodie abscess |
|
|
|
|
|
|
Osteoma |
|
|
|
|
|
|
Intraosseous lipoma |
|
|
|
|
|
|
Enostosis |
|
|
|
|
|
|
Chordoma |
|
|
|
|
|
|
Bone metastasis |
|
|
|
|
|
|
Intraosseous ganglion |
|
|
|
|
|
|